Switch to:
Also traded in: Germany, Mexico, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.02
HCA's Cash-to-Debt is ranked lower than
94% of the 274 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
HCA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.14
Current: 0.02
0
0.14
Equity-to-Asset -0.15
HCA's Equity-to-Asset is ranked lower than
97% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. HCA: -0.15 )
Ranked among companies with meaningful Equity-to-Asset only.
HCA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.21 Max: 0.42
Current: -0.15
-0.5
0.42
Debt-to-Equity -5.91
HCA's Debt-to-Equity is ranked lower than
99.99% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. HCA: -5.91 )
Ranked among companies with meaningful Debt-to-Equity only.
HCA' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.91  Med: 0.87 Max: 4.71
Current: -5.91
-5.91
4.71
Debt-to-EBITDA 3.59
HCA's Debt-to-EBITDA is ranked lower than
63% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. HCA: 3.59 )
Ranked among companies with meaningful Debt-to-EBITDA only.
HCA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.59  Med: 4.26 Max: 5.86
Current: 3.59
3.59
5.86
Interest Coverage 3.74
HCA's Interest Coverage is ranked lower than
69% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 6.85 vs. HCA: 3.74 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.45  Med: 2.64 Max: 3.74
Current: 3.74
1.45
3.74
Piotroski F-Score: 7
Altman Z-Score: 2.43
WACC vs ROIC
7.37%
16.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.19
HCA's Operating Margin % is ranked higher than
72% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.83 vs. HCA: 14.19 )
Ranked among companies with meaningful Operating Margin % only.
HCA' s Operating Margin % Range Over the Past 10 Years
Min: 10.34  Med: 14.6 Max: 15.07
Current: 14.19
10.34
15.07
Net Margin % 6.96
HCA's Net Margin % is ranked higher than
57% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.88 vs. HCA: 6.96 )
Ranked among companies with meaningful Net Margin % only.
HCA' s Net Margin % Range Over the Past 10 Years
Min: 2.37  Med: 4.97 Max: 8.3
Current: 6.96
2.37
8.3
ROA % 8.62
HCA's ROA % is ranked higher than
71% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. HCA: 8.62 )
Ranked among companies with meaningful ROA % only.
HCA' s ROA % Range Over the Past 10 Years
Min: 2.79  Med: 6.06 Max: 9.71
Current: 8.62
2.79
9.71
ROC (Joel Greenblatt) % 32.23
HCA's ROC (Joel Greenblatt) % is ranked higher than
68% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 14.91 vs. HCA: 32.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HCA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.15  Med: 30.35 Max: 37.66
Current: 32.23
23.15
37.66
3-Year Revenue Growth Rate 12.60
HCA's 3-Year Revenue Growth Rate is ranked higher than
71% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. HCA: 12.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HCA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.8  Med: 8.1 Max: 24.3
Current: 12.6
-7.8
24.3
3-Year EBITDA Growth Rate 12.10
HCA's 3-Year EBITDA Growth Rate is ranked higher than
67% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. HCA: 12.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HCA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -40.4  Med: 8.6 Max: 76.1
Current: 12.1
-40.4
76.1
3-Year EPS without NRI Growth Rate 12.70
HCA's 3-Year EPS without NRI Growth Rate is ranked higher than
57% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. HCA: 12.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HCA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.7 Max: 88.4
Current: 12.7
0
88.4
GuruFocus has detected 3 Warning Signs with HCA Healthcare Inc HCA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCA's 30-Y Financials

Financials (Next Earnings Date: 2019-01-31 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

HCA Guru Trades in Q3 2017

Charles Brandes 686,968 sh (+441.67%)
Lee Ainslie 68,850 sh (+47.91%)
Bill Nygren 2,916,000 sh (+31.59%)
First Pacific Advisors 20,500 sh (+24.24%)
David Tepper 183,711 sh (+9.54%)
David Dreman 21,298 sh (+7.72%)
Larry Robbins 15,155,942 sh (+1.72%)
Vanguard Health Care Fund 11,002,078 sh (unchged)
John Hussman 75,800 sh (unchged)
Mario Gabelli 49,500 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 224,376 sh (unchged)
Jim Simons Sold Out
John Paulson Sold Out
Joel Greenblatt 327,576 sh (-3.47%)
Glenn Greenberg 2,918,273 sh (-5.26%)
Jeremy Grantham 3,400 sh (-97.63%)
» More
Q4 2017

HCA Guru Trades in Q4 2017

Pioneer Investments 198,083 sh (New)
Leucadia National 5,826 sh (New)
Steven Cohen 501,826 sh (New)
David Tepper 552,884 sh (+200.95%)
Bill Nygren 4,316,000 sh (+48.01%)
Mario Gabelli 49,500 sh (unchged)
Lee Ainslie Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Glenn Greenberg 2,905,777 sh (-0.43%)
Charles Brandes 675,835 sh (-1.62%)
Vanguard Health Care Fund 10,517,578 sh (-4.40%)
Larry Robbins 12,351,122 sh (-18.51%)
John Hussman 50,800 sh (-32.98%)
David Dreman 8,979 sh (-57.84%)
First Pacific Advisors 6,000 sh (-70.73%)
Eaton Vance Worldwide Health Sciences Fund 209,606 sh (-6.58%)
» More
Q1 2018

HCA Guru Trades in Q1 2018

Jim Simons 380,100 sh (New)
Lee Ainslie 13,570 sh (New)
Paul Tudor Jones 30,297 sh (New)
George Soros 200,000 sh (New)
Leucadia National 18,436 sh (+216.44%)
Pioneer Investments 208,117 sh (+5.07%)
Bill Nygren 4,316,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund Sold Out
Steven Cohen 497,743 sh (-0.81%)
Larry Robbins 11,859,592 sh (-3.98%)
Charles Brandes 646,780 sh (-4.30%)
Glenn Greenberg 2,722,358 sh (-6.31%)
Vanguard Health Care Fund 9,570,578 sh (-9.00%)
David Dreman 7,364 sh (-17.99%)
John Hussman 40,800 sh (-19.69%)
Mario Gabelli 38,000 sh (-23.23%)
First Pacific Advisors 4,200 sh (-30.00%)
David Tepper 282,884 sh (-48.83%)
» More
Q2 2018

HCA Guru Trades in Q2 2018

First Eagle Investment 2,290,037 sh (New)
Joel Greenblatt 104,824 sh (New)
Pioneer Investments 774,046 sh (+271.93%)
Jim Simons 1,094,431 sh (+187.93%)
Leucadia National 34,414 sh (+86.67%)
John Hussman 40,800 sh (unchged)
Mario Gabelli 38,000 sh (unchged)
First Pacific Advisors 4,200 sh (unchged)
Bill Nygren 4,316,000 sh (unchged)
George Soros Sold Out
Paul Tudor Jones Sold Out
Lee Ainslie Sold Out
David Tepper Sold Out
Glenn Greenberg 2,710,384 sh (-0.44%)
Charles Brandes 604,320 sh (-6.56%)
Vanguard Health Care Fund 8,200,145 sh (-14.32%)
Larry Robbins 5,332,923 sh (-55.03%)
Steven Cohen 135,000 sh (-72.88%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:XTER:FME, XTER:FRE, XKLS:5225, SZSE:300015, NYSE:DVA, BKK:BDMS, NYSE:UHS, LSE:NMC, ASX:RHC, ASX:SHL, LSE:MDC, NYSE:EHC, NYSE:CHE, NYSE:EVHC, BKK:BH, NYSE:MD, JSE:LHC, JSE:NTC, NAS:ACHC, NYSE:AMN » details
Traded in other countries:2BH.Germany, HCA.Mexico, 0J1R.UK,
Headquarter Location:USA
HCA Healthcare Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals, and rehabilitation hospitals. The company also operates freestanding surgery centers.

Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the United States. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services. HCA has operations in 20 states and in England, but a majority of its operations are in the Southern United States, particularly in Florida and Texas. Outpatient services make up about 40% of HCA's patient revenue.

Guru Investment Theses on HCA Healthcare Inc

Bill Nygren Comments on HCA - Jan 10, 2017

HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value.

From Bill Nygren (Trades, Portfolio)'s Oakmark Fund fourth quarter 2016 commentary.

Check out Bill Nygren latest stock trades

Top Ranked Articles about HCA Healthcare Inc

Reston Hospital Center Launches Training Program for Robotic Guided Spine Surgery
Mission Health Signs Definitive Agreement To Be Acquired By HCA Healthcare
Consolidated Research: 2018 Summary Expectations for HCA Healthcare, The AES, Hercules Capital, Carrizo Oil & Gas, Callon Petroleum, and Ultra Clean — Fundamental Analysis, Key Performance Indications
8 Stocks David Tepper Continues to Buy The guru added to these positions in the past 2 quarters
David Tepper (TradesPortfolio) is the founder of Appaloosa Management. He invested in the following Read more...
3 Stocks Move in Premarket Trading Tuesday Chesapeake and Nucor fall, HCA Healthcare rises
In Tuesday premarket trading, Chesapeake Energy (NYSE:CHK) lost 5% after the company announced it will reduce its workforce by 13%, or 400 people, primarily at its Oklahoma City headquarters.  Read more...
Regional Medical Center of San Jose is pleased to announce that Kenneth M. West, FACHE has accepted the position of Chief Operating Officer at Regional Medical Center of San Jose, effective February 5th.
Regional Medical Center of San Jose is pleased to announce that Kenneth M. West, FACHE has accepted the position of Chief Operating Officer at Regional Medical Center of San Jose, effective February 5th.

Ratios

vs
industry
vs
history
PE Ratio 15.67
HCA's PE Ratio is ranked higher than
77% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 27.31 vs. HCA: 15.67 )
Ranked among companies with meaningful PE Ratio only.
HCA' s PE Ratio Range Over the Past 10 Years
Min: 4.08  Med: 13.42 Max: 19.67
Current: 15.67
4.08
19.67
Forward PE Ratio 13.89
HCA's Forward PE Ratio is ranked higher than
93% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 20.66 vs. HCA: 13.89 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 15.67
HCA's PE Ratio without NRI is ranked higher than
77% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HCA: 15.67 )
Ranked among companies with meaningful PE Ratio without NRI only.
HCA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.08  Med: 13.42 Max: 19.67
Current: 15.67
4.08
19.67
Price-to-Owner-Earnings 14.90
HCA's Price-to-Owner-Earnings is ranked higher than
63% of the 109 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. HCA: 14.90 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.31  Med: 13.77 Max: 43.21
Current: 14.9
2.31
43.21
PS Ratio 1.09
HCA's PS Ratio is ranked higher than
73% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. HCA: 1.09 )
Ranked among companies with meaningful PS Ratio only.
HCA' s PS Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.72 Max: 1.12
Current: 1.09
0.32
1.12
Price-to-Free-Cash-Flow 17.20
HCA's Price-to-Free-Cash-Flow is ranked higher than
71% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 23.01 vs. HCA: 17.20 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.08  Med: 11.91 Max: 20.84
Current: 17.2
4.08
20.84
Price-to-Operating-Cash-Flow 7.95
HCA's Price-to-Operating-Cash-Flow is ranked higher than
82% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 14.67 vs. HCA: 7.95 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.57  Med: 5.87 Max: 8.64
Current: 7.95
2.57
8.64
EV-to-EBIT 11.87
HCA's EV-to-EBIT is ranked higher than
86% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 21.68 vs. HCA: 11.87 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.6 Max: 12.6
Current: 11.87
6.3
12.6
EV-to-EBITDA 8.98
HCA's EV-to-EBITDA is ranked higher than
85% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. HCA: 8.98 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.9 Max: 9.4
Current: 8.98
5
9.4
EV-to-Revenue 1.80
HCA's EV-to-Revenue is ranked higher than
62% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. HCA: 1.80 )
Ranked among companies with meaningful EV-to-Revenue only.
HCA' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2  Med: 1.5 Max: 1.9
Current: 1.8
1.2
1.9
PEG Ratio 1.41
HCA's PEG Ratio is ranked higher than
74% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 3.13 vs. HCA: 1.41 )
Ranked among companies with meaningful PEG Ratio only.
HCA' s PEG Ratio Range Over the Past 10 Years
Min: 0.51  Med: 1.82 Max: 4.61
Current: 1.41
0.51
4.61
Shiller PE Ratio 25.07
HCA's Shiller PE Ratio is ranked higher than
76% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 31.76 vs. HCA: 25.07 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.16  Med: 15.85 Max: 25.75
Current: 25.07
6.16
25.75
Current Ratio 1.61
HCA's Current Ratio is ranked higher than
60% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. HCA: 1.61 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.52 Max: 2.25
Current: 1.61
0.81
2.25
Quick Ratio 1.34
HCA's Quick Ratio is ranked higher than
56% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. HCA: 1.34 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.35 Max: 2.12
Current: 1.34
0.71
2.12
Days Inventory 20.45
HCA's Days Inventory is ranked lower than
87% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 17.07 vs. HCA: 20.45 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 17.77  Med: 19.82 Max: 57.7
Current: 20.45
17.77
57.7
Days Sales Outstanding 51.87
HCA's Days Sales Outstanding is ranked lower than
68% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 39.87 vs. HCA: 51.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.91 Max: 56.3
Current: 51.87
44.84
56.3
Days Payable 30.60
HCA's Days Payable is ranked higher than
77% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 40.58 vs. HCA: 30.60 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 30.44  Med: 32.3 Max: 109.47
Current: 30.6
30.44
109.47

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.75
HCA's Dividend Yield % is ranked lower than
93% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. HCA: 0.75 )
Ranked among companies with meaningful Dividend Yield % only.
HCA' s Dividend Yield % Range Over the Past 10 Years
Min: 0.34  Med: 0.61 Max: 0.82
Current: 0.75
0.34
0.82
Dividend Payout Ratio 0.12
HCA's Dividend Payout Ratio is ranked lower than
99.99% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 0.43 vs. HCA: 0.12 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HCA' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.12
Current: 0.12
0
0.12
Forward Dividend Yield % 1.00
HCA's Forward Dividend Yield % is ranked lower than
62% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. HCA: 1.00 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.75
HCA's 5-Year Yield-on-Cost % is ranked lower than
95% of the 325 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. HCA: 0.75 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HCA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.34  Med: 0.61 Max: 0.82
Current: 0.75
0.34
0.82
3-Year Average Share Buyback Ratio 5.90
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HCA: 5.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -202.3  Med: 1.3 Max: 12
Current: 5.9
-202.3
12

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.71
HCA's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
64% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. HCA: 1.71 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.26  Med: 2.65 Max: 17.96
Current: 1.71
1.26
17.96
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.46
HCA's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
99.99% of the 33 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. HCA: 1.46 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
HCA' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.81  Med: 1.35 Max: 1.74
Current: 1.46
0.81
1.74
Price-to-Median-PS-Value 1.51
HCA's Price-to-Median-PS-Value is ranked lower than
68% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. HCA: 1.51 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5  Med: 1.01 Max: 1.51
Current: 1.51
0.5
1.51
Price-to-Peter-Lynch-Fair-Value 1.16
HCA's Price-to-Peter-Lynch-Fair-Value is ranked higher than
78% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.08 vs. HCA: 1.16 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HCA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.58  Med: 1.66 Max: 3.7
Current: 1.16
0.58
3.7
Earnings Yield (Greenblatt) % 8.42
HCA's Earnings Yield (Greenblatt) % is ranked higher than
89% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. HCA: 8.42 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 8  Med: 9.4 Max: 16
Current: 8.42
8
16
Forward Rate of Return (Yacktman) % 17.96
HCA's Forward Rate of Return (Yacktman) % is ranked higher than
74% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 9.10 vs. HCA: 17.96 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.8  Med: 14.1 Max: 19.8
Current: 17.96
9.8
19.8

More Statistics

Revenue (TTM) (Mil) $45,965.00
EPS (TTM) $ 8.95
Beta1.14
Volatility27.38%
52-Week Range $74.26 - 144.96
Shares Outstanding (Mil)344.16

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 46,351 48,457 50,829
EBIT (Mil $) 6,658 7,436 7,613
EBITDA (Mil $) 8,771 9,266 10,025
EPS ($) 9.34 10.17 11.96
EPS without NRI ($) 9.34 10.17 11.96
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.82%
Dividends per Share ($) 0.70 0.70

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}